• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Susceptibility of Diabetic Patients to COVID-19 Infections: Clinico-Hematological and Complications Analysis.糖尿病患者对2019冠状病毒病感染的易感性:临床血液学及并发症分析
Vaccines (Basel). 2023 Mar 1;11(3):561. doi: 10.3390/vaccines11030561.
2
Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study.加纳住院 COVID-19 合并 2 型糖尿病患者的临床和实验室特征及转归:一项单中心研究。
Endocrinol Diabetes Metab. 2023 Jan;6(1):e391. doi: 10.1002/edm2.391. Epub 2022 Nov 25.
3
Susceptibility of ABO blood group to COVID-19 infections: clinico-hematological, radiological, and complications analysis.ABO 血型对 COVID-19 感染的易感性:临床血液学、影像学和并发症分析。
Medicine (Baltimore). 2021 Dec 30;100(52):e28334. doi: 10.1097/MD.0000000000028334.
4
Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.沙特阿拉伯住院患者中的糖尿病和新冠病毒-19:一项单中心回顾性研究。
Cardiovasc Diabetol. 2020 Dec 5;19(1):205. doi: 10.1186/s12933-020-01184-4.
5
Diabetes Mellitus and Related Admission Factors Among Hospitalized Patients in King Abdul-Aziz University Hospital in Jeddah, Saudi Arabia.沙特阿拉伯吉达阿卜杜勒 - 阿齐兹国王大学医院住院患者中的糖尿病及相关入院因素
Cureus. 2022 May 25;14(5):e25312. doi: 10.7759/cureus.25312. eCollection 2022 May.
6
Clinical characteristics of non-intensive care unit COVID-19 patients in Saudi Arabia: A descriptive cross-sectional study.沙特阿拉伯非重症监护病房 COVID-19 患者的临床特征:一项描述性横断面研究。
J Infect Public Health. 2020 Nov;13(11):1639-1644. doi: 10.1016/j.jiph.2020.09.003. Epub 2020 Sep 21.
7
Overview of clinical outcome and therapeutic effectiveness of Favipiravir in patients with COVID-19 admitted to intensive care unit, Riyadh, Saudi Arabia.沙特阿拉伯利雅得重症监护病房 COVID-19 患者使用法维拉韦的临床转归和治疗效果概述。
J Infect Public Health. 2022 Apr;15(4):389-394. doi: 10.1016/j.jiph.2022.01.013. Epub 2022 Feb 15.
8
Clinical Characteristics and Factors Associated with Poor Outcomes in Hospitalized Patients with Novel Coronavirus Infection COVID-19.新型冠状病毒感染 COVID-19 住院患者的临床特征及不良预后相关因素。
Kardiologiia. 2021 Mar 1;61(2):4-14. doi: 10.18087/cardio.2021.2.n1532.
9
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.一项评估法匹拉韦和羟氯喹联合治疗中重度 COVID-19 住院成人的疗效和安全性的随机对照研究:研究方案的结构化总结。
Trials. 2020 Oct 31;21(1):904. doi: 10.1186/s13063-020-04825-x.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
The resident gut microbiome modulates the effect of synbiotics on the immunogenicity after SARS-COV-2 vaccination in elderly and diabetes patients.肠道常驻微生物群调节了合生元对老年和糖尿病患者接种新型冠状病毒疫苗后免疫原性的影响。
NPJ Biofilms Microbiomes. 2025 Aug 25;11(1):171. doi: 10.1038/s41522-025-00804-9.
2
Type 2 diabetes mellitus as a predictor of severe outcomes in COVID-19 - a systematic review and meta-analyses.2型糖尿病作为COVID-19严重结局的预测因素——一项系统评价和荟萃分析
BMC Infect Dis. 2025 May 19;25(1):719. doi: 10.1186/s12879-025-11089-w.
3
The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19.血糖控制在重症2型糖尿病合并新型冠状病毒肺炎患者炎症标志物及临床结局中的作用
Biomedicines. 2025 Apr 6;13(4):886. doi: 10.3390/biomedicines13040886.
4
A Review on Risk Factors, Traditional Diagnostic Techniques, and Biomarkers for Pneumonia Prognostication and Management in Diabetic Patients.糖尿病患者肺炎预后与管理的危险因素、传统诊断技术及生物标志物综述
Diseases. 2024 Dec 2;12(12):310. doi: 10.3390/diseases12120310.
5
Prognostic Utility of dNLR, ALRI, APRI, and SII in COVID-19 Patients with Diabetes: A Cross-Sectional Study.中性粒细胞与淋巴细胞比值、急性肝-肾指数、天冬氨酸氨基转移酶与血小板比值指数及全身免疫炎症指数在2型糖尿病合并新型冠状病毒肺炎患者中的预后价值:一项横断面研究
Diagnostics (Basel). 2024 Aug 4;14(15):1685. doi: 10.3390/diagnostics14151685.
6
Comparative Analysis of COVID-19 Outcomes in Type 1 and Type 2 Diabetes: A Three-Year Retrospective Study.1 型和 2 型糖尿病患者 COVID-19 结局的对比分析:一项为期三年的回顾性研究。
Medicina (Kaunas). 2024 Jan 25;60(2):210. doi: 10.3390/medicina60020210.

本文引用的文献

1
Cancer of the Liver and its Relationship with Diabetes mellitus.肝癌及其与糖尿病的关系。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221119743. doi: 10.1177/15330338221119743.
2
Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression.细胞增殖减少通过限制 FcεRIγ 表达促进自然杀伤细胞适应性样表型。
J Exp Med. 2022 Nov 7;219(11). doi: 10.1084/jem.20220551. Epub 2022 Sep 6.
3
Associations of Clinical Factors and Blood Groups With the Severity of COVID-19 Infection in Makkah City, Saudi Arabia.临床因素和血型与沙特阿拉伯麦加市 COVID-19 感染严重程度的相关性。
Front Cell Infect Microbiol. 2022 Jun 21;12:870096. doi: 10.3389/fcimb.2022.870096. eCollection 2022.
4
Impact of COVID-19 therapy on hyperglycemia.COVID-19 治疗对高血糖的影响。
Diab Vasc Dis Res. 2022 May-Jun;19(3):14791641221095091. doi: 10.1177/14791641221095091.
5
Multiple early factors anticipate post-acute COVID-19 sequelae.多种早期因素预示着急性新冠病毒感染后会出现长期新冠症状。
Cell. 2022 Mar 3;185(5):881-895.e20. doi: 10.1016/j.cell.2022.01.014. Epub 2022 Jan 25.
6
The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It.2019冠状病毒病对合并症的影响:抗击该病的最新进展综述
Saudi J Biol Sci. 2022 May;29(5):3586-3599. doi: 10.1016/j.sjbs.2022.02.006. Epub 2022 Feb 10.
7
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.早期 IFN-α 特征和持续功能障碍是严重 COVID-19 中 NK 细胞的显著特征。
Immunity. 2021 Nov 9;54(11):2650-2669.e14. doi: 10.1016/j.immuni.2021.09.002. Epub 2021 Sep 4.
8
Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19.血浆和单细胞的综合分析揭示了 COVID-19 患者的代谢变化。
Nat Biotechnol. 2022 Jan;40(1):110-120. doi: 10.1038/s41587-021-01020-4. Epub 2021 Sep 6.
9
Post COVID-19 Syndrome ("Long COVID") and Diabetes: Challenges in Diagnosis and Management.新冠后综合征(“长新冠”)与糖尿病:诊断与管理面临的挑战。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102235. doi: 10.1016/j.dsx.2021.102235. Epub 2021 Jul 28.
10
Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K.更高的入院激活部分凝血活酶时间、中性粒细胞-淋巴细胞比值、血清钠和抗凝药物的使用预测英国两所大学医院糖尿病患者的 COVID-19 住院死亡率:研究结果
Diabetes Res Clin Pract. 2021 Aug;178:108955. doi: 10.1016/j.diabres.2021.108955. Epub 2021 Jul 14.

糖尿病患者对2019冠状病毒病感染的易感性:临床血液学及并发症分析

Susceptibility of Diabetic Patients to COVID-19 Infections: Clinico-Hematological and Complications Analysis.

作者信息

Atwah Banan, Iqbal Mohammad Shahid, Kabrah Saeed, Kabrah Ahmed, Alghamdi Saad, Tabassum Aisha, Baghdadi Mohammed A, Alzahrani Hissah

机构信息

Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 21955, Saudi Arabia.

Research Center, King Faisal Specialist Hospital and Research Centre (KFSH&RC), Jeddah 23431, Saudi Arabia.

出版信息

Vaccines (Basel). 2023 Mar 1;11(3):561. doi: 10.3390/vaccines11030561.

DOI:10.3390/vaccines11030561
PMID:36992148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10056589/
Abstract

BACKGROUND

Coronavirus disease 2019 has become a global health threat resulting in a catastrophic spread and more than 3.8 million deaths worldwide. It has been suggested that there is a negative influence of diabetes mellites (DM), which is a complex chronic disease, on COVID-19 severe outcomes. Other factors in diabetic patients may also contribute to COVID-19 disease outcomes, such as older age, obesity, hyperglycaemia, hypertension, and other chronic conditions.

METHODS

A cohort study was conducted on the demographics, clinical information, and laboratory findings of the hospitalised COVID-19 with DM and non-DM patients were obtained from the medical records in King Faisal Specialist Hospital and Research Centre, Saudi Arabia.

RESULTS

Among the study population, 108 patients had DM, and 433 were non-DM patients. Patients with DM were more likely to present symptoms such as fever (50.48%), anorexia (19.51%), dry cough (47.96%), shortness of breath (35.29%), chest pain (16.49%), and other symptoms. There was a significant decrease in the mean of haematological and biochemical parameters, such as haemoglobin, calcium, and alkaline phosphate in people with diabetes compared to non-diabetics and a considerable increase in other parameters, such as glucose, potassium, and cardiac troponin.

CONCLUSIONS

According to the findings of this study, patients who have diabetes have a greater risk of developing more severe symptoms associated with COVID-19 disease. This could result in more patients being admitted to the intensive care unit as well as higher mortality rates.

摘要

背景

2019冠状病毒病已成为全球健康威胁,在全球范围内造成灾难性传播,导致超过380万人死亡。有人提出,作为一种复杂的慢性病,糖尿病(DM)对2019冠状病毒病的严重后果有负面影响。糖尿病患者的其他因素也可能影响2019冠状病毒病的病情转归,如年龄较大、肥胖、高血糖、高血压和其他慢性病。

方法

对沙特阿拉伯法赫德国王专科医院和研究中心收治的2019冠状病毒病合并糖尿病患者和非糖尿病患者的人口统计学、临床信息和实验室检查结果进行队列研究,数据来自病历记录。

结果

在研究人群中,108例患者患有糖尿病,433例为非糖尿病患者。糖尿病患者更易出现发热(50.48%)、厌食(19.51%)、干咳(47.96%)、气短(35.29%)、胸痛(16.49%)等症状。与非糖尿病患者相比,糖尿病患者血液学和生化指标如血红蛋白、钙和碱性磷酸酶的平均值显著降低,而血糖、钾和心肌肌钙蛋白等其他指标则显著升高。

结论

根据本研究结果,糖尿病患者感染2019冠状病毒病后出现更严重症状的风险更高。这可能导致更多患者入住重症监护病房,死亡率也更高。